Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen: a novel vaccine for cancer therapy. (Q38754223)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen: a novel vaccine for cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

Mycobacterium tuberculosis

20 March 2020

main subject

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Tomoko Ito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Aya Hasegawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Masazumi Eriguchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Toshio Inaba

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Takahiro Ushigusa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Kikuya Sugiura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

1 reference

2 August 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

published in

Biotechnology Letters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

1857-1866

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

Tumor-derived exosomes: a new source of tumor rejection antigens

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Malignant effusions and immunogenic tumour-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Whole Tumor Antigen Vaccines: Where Are We?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Mycobacterium tuberculosis ESAT-6 exhibits a unique membrane-interacting activity that is not found in its ortholog from non-pathogenic Mycobacterium smegmatis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Recent advances on the role of tumor exosomes in immunosuppression and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

High Efficiency DNA-Mediated Transformation of Primate Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Antitumor effect of chondroitin sulfate-coated ternary granulocyte macrophage-colony-stimulating factor plasmid complex for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

DNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Preparation of calcium phosphate nanocapsule including deoxyribonucleic acid-polyethyleneimine-hyaluronic acid ternary complex for durable gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Exosomes biological significance: A concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Novel Antitumor Strategy Utilizing a Plasmid Expressing a Mycobacterium tuberculosis Antigen as a "Danger Signal" to Block Immune Escape of Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Highly Effective Non-Viral Antitumor Gene Therapy System Comprised of Biocompatible Small Plasmid Complex Particles Consisting of pDNA, Anionic Polysaccharide, and Fully Deprotected Linear Polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from the vacuole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Tumor-released microvesicles as vehicles of immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2185-1

10.1007/S10529-016-2185-1

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27484689%20AND%20SRC:MED&resulttype=core&format=json